article thumbnail

Open Source “Wikipedia” for Drug Discovery

Pharma Mirror

Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation. In 2003 the Human Genome Project provided the first atlas.

article thumbnail

Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh

Pharma Mirror

The post Rashedi Hassan takes over Sales & Marketing management of Telstar’s subsidiary in Bangladesh appeared first on Pharma Mirror Magazine. Rashedi Hassan holds a Diploma in Engineering from Dhaka Polytechnic Institute. With more than 18.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Leverage Omnichannel & Sales Enablement Technologies for Pharmaceutical Sales Success

Pharma Mirror

In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs).

article thumbnail

Neuraxpharm completes its presence in Benelux

Pharma Mirror

Neuraxpharm Belgium will be based in Brussels and will distribute and market prescription brand The post Neuraxpharm completes its presence in Benelux appeared first on Pharma Mirror Magazine.

article thumbnail

Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines

Pharma Mirror

Bandung, W Java, Indonesia, PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing of IndoVac, a Covid-19 vaccine brand it has developed since November 2021.

article thumbnail

Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc

Pharma Mirror

Nanjing (China) and Barcelona (Spain), a global biopharmaceutical company focused on skin health, and Simcere Pharmaceutical Group(2096.HK), The post Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc appeared first on Pharma Mirror Magazine.

article thumbnail

Dr. August Wolff and Cantabria Labs enter into an exclusive commercialization agreement for Southern Europe for hyperhidrosis product

Pharma Mirror

The German pharmaceutical company Dr. August Wolff GmbH & Co. Wolff”) and the Spanish pharmaceutical company Cantabria Labs (“Cantabria Labs”) concluded a strategic partnership on March 12th 2021 by entering into an exclusive licensing agreement for a newly developed medicinal product for the treatment of hyperhidrosis.